What has FDA cited under ICH Q8(R2)?

1 DSRV article cite ICH Q8(R2). Enforcement cases behind them: FDA final Level 2 guidance, ICH Q8, Q9, and Q10 Questions and Answers (R5), adopted May 29, 2026 under docket FDA-2017-D-6821. Inspection exposure across them: 1 moderate.

What does DSRV recommend for ICH Q8(R2)?

From the newest article (ICH Q8/Q9/Q10 R5 Just Raised the Floor on Risk Documentation): The decisive question is no longer whether a risk assessment was completed but whether its criteria, thresholds, and acceptability logic are explicit enough in the record to be defended without the author in the room. DSRV is decision support, not legal advice; verify against the official source each article names.

Browse by regulation1 article · 1 moderate

ICH Q8(R2)

Every DSRV article whose Regulatory Snapshot cites ICH Q8(R2): the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set

What has FDA cited under ICH Q8(R2)?: 1 DSRV article cite ICH Q8(R2). Enforcement cases behind them: FDA final Level 2 guidance, ICH Q8, Q9, and Q10 Questions and Answers (R5), adopted May 29, 2026 under docket FDA-2017-D-6821. Inspection exposure across them: 1 moderate.
What does DSRV recommend for ICH Q8(R2)?: From the newest article (ICH Q8/Q9/Q10 R5 Just Raised the Floor on Risk Documentation): The decisive question is no longer whether a risk assessment was completed but whether its criteria, thresholds, and acceptability logic are explicit enough in the record to be defended without the author in the room. DSRV is decision support, not legal advice; verify against the official source each article names.

June 20264 min readModerate exposurecited as a tag
ICH Q8/Q9/Q10 R5 Just Raised the Floor on Risk Documentation
FDA adopted ICH Q8/Q9/Q10 R5 as final Level 2 guidance on May 29, 2026. The alignment with Q9(R1) is the change that matters most for quality systems that still rely on informal risk judgments.
Case
FDA final Level 2 guidance, ICH Q8, Q9, and Q10 Questions and Answers (R5), adopted May 29, 2026 under docket FDA-2017-D-6821.
DSRV take
The decisive question is no longer whether a risk assessment was completed but whether its criteria, thresholds, and acceptability logic are explicit enough in the record to be defended without the author in the room.

Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under ICH Q8(R2). DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about ICH Q8(R2)

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.